These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17302713)

  • 21. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P; Tulner SA; Bax JJ; Oemrawsingh PV; Bleeker GB; van Erven L; Putter H; Verwey HF; van der Wall EE; Schalij MJ
    Circulation; 2006 Mar; 113(10):1295-304. PubMed ID: 16520415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
    Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical appraisal of the use of cardiac resynchronization therapy beyond current guidelines.
    Van Bommel RJ; Delgado V; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Aug; 56(10):754-62. PubMed ID: 20797487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LV based pacing in patients with heart failure and a narrow QRS--an acute hemodynamic study.
    Dwivedi S; Sheth C; Puri A; Narain V; Saran R; Puri V
    Indian Heart J; 2007; 59(3):250-5. PubMed ID: 19124935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.
    Fung JW; Zhang Q; Yip GW; Chan JY; Chan HC; Yu CM
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between QRS complex notch and ventricular dyssynchrony in patients with heart failure and prolonged QRS duration.
    Fazelifar AF; Bonakdar HR; Alizadeh K; Azarnik H; Haghjoo M; Abkenar HB; Samiei N; Sadr-Ameli MA
    Cardiol J; 2008; 15(4):351-6. PubMed ID: 18698544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure.
    Molhoek SG; Bax JJ; Bleeker GB; Holman ER; Van Erven L; Bootsma M; Boersma E; Steendijk P; Van Der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):701-7. PubMed ID: 16050826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac resynchronization therapy in patients with mildly impaired left ventricular function.
    Foley PW; Stegemann B; Smith RE; Sanderson JE; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S186-9. PubMed ID: 19250090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy.
    Gorcsan J; Tanabe M; Bleeker GB; Suffoletto MS; Thomas NC; Saba S; Tops LF; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2007 Oct; 50(15):1476-83. PubMed ID: 17919568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.